Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
90-33-5
Molecular formula
C10H8O3
Molecular weight
176.1687 g/mol
Drug class
Coumarin derivativecholeretic and biliary smooth-muscle spasmolytic
Mechanism of action
Promotes bile flow and has reported spasmolytic activity in the biliary tract. Its precise molecular mechanism is not fully established.
Indications / reported uses
Symptomatic treatment of biliary tract spasm and dyspeptic symptoms associated with biliary dysfunction in countries where hymecromone is authorised.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Hymecromone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Hymecromone Permitted Daily Exposure (PDE) report (the Hymecromone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Hymecromone Occupational Exposure Limit (OEL) report (the Hymecromone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.